Search

everythinglearnresearchcommunity

for

Search:↓

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Apoptosis is crucial for healthy skin and treating skin diseases.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

Chikungunya virus often causes skin issues and inflammation.

Special cells can help regrow hair in alopecia areata.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Cancer treatments often cause skin, nail, and hair problems.

CT60 polymorphism might increase the risk of Alopecia Areata.

A genetic marker linked to a type of hair loss was found in most patients studied.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

CD2 might be a new treatment target for patchy alopecia areata.

Regulatory T cells are essential for normal and improved wound healing in mice.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.